# JAGX (Jaguar Health, Inc.) - SEC EDGAR Financial Statements

> Jaguar Health, Inc. reported $27.07M in revenue and a net loss of $49.23M for the trailing twelve months ended September 30, 2026 (down 24.0% year over year), with a 81.5% gross margin and a -91.2% operating margin.

- Canonical: https://convexityos.com/fundamentals/JAGX
- Markdown: https://convexityos.com/fundamentals/JAGX.md
- SEC CIK: 0001585608
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:13 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001585608&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $27.07M | -24.0% YoY |
| Operating Income | TTM | -$24.68M | -91.2% margin |
| Net Income | TTM | -$49.23M | -181.8% net margin |
| Diluted EPS | TTM | -$71.94 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $5.53M | Total debt: $1.02M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $11.51M | $11.69M | $9.76M | $11.96M | $4.33M | $9.38M | $5.78M | $4.42M | $4.36M | $142K |
| Cost of Revenue | $3.77M | $1.96M | $2.04M | $2.02M | $2.33M | $3.28M | $3.82M | $2.77M | $880K | $52K |
| **Gross Profit** | $7.74M | $9.73M | $7.72M | $9.94M | $2.00M | $6.11M | $1.96M | $1.65M | $3.48M | $90K |
| Research & Development | $24.97M | $16.54M | $18.60M | $17.65M | $15.08M | $6.41M | $5.82M | $5.15M | $4.27M | $7.21M |
| Selling, General & Admin | $27.88M | $24.02M | $23.05M | $26.70M | $26.00M | $21.00M | $20.44M | $22.11M | $14.33M | $6.47M |
| Total Operating Expenses | -- | -- | -- | -- | -- | -- | -- | $35.24M | $38.61M | $13.73M |
| **Operating Income** | -$45.91M | -$30.83M | -$34.29M | -$34.41M | -$40.71M | -$26.65M | -$28.95M | -$30.82M | -$34.25M | -$13.59M |
| **EBITDA** | -$43.99M | -$28.93M | -$32.28M | -$32.43M | -$38.99M | -$24.92M | -$27.21M | -$29.50M | -$33.66M | -$13.54M |
| Interest Expense | $67K | $231K | $6.38M | $12.72M | $8.42M | $2.79M | $5.73M | $2.63M | $1.21M | $986K |
| Income Before Tax | -$54.00M | -$39.25M | -$41.90M | -$48.40M | -$52.60M | -$33.81M | -$38.53M | -$32.15M | -$35.15M | -$14.73M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $10K | -- | -$13.18M | -- |
| **Net Income** | -$53.58M | -$38.49M | -$41.30M | -$47.45M | -$52.59M | -$33.81M | -$38.54M | -$32.15M | -$21.97M | -$14.73M |
| Basic EPS | -$2,045,365,500.37 | -$11,637,301,577.88 | -$60,087,087,598,772.13 | -$619,373,631,556,875,714,560.00 | -$86,796,448,434,626,949,545,984.00 | -$665,772,373,502,029,794,902,016.00 | -$59,992,090,061,539,026,927,616.00 | -$1,020,531,370,003,561,319,497,728.00 | -$3,369,145,124,432,714,609,459,200.00 | -$8,988,825,924,869,892,354,342,912.00 |
| **Diluted EPS** | -$2,045,365,500.37 | -$11,637,301,577.88 | -$60,087,087,598,772.13 | -$619,373,631,556,875,714,560.00 | -$86,796,448,434,626,949,545,984.00 | -$665,772,373,502,029,794,902,016.00 | -$59,992,090,061,539,026,927,616.00 | -$1,020,531,370,003,561,319,497,728.00 | -$3,369,145,124,432,714,609,459,200.00 | -$8,988,825,924,869,892,354,342,912.00 |
| Basic Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $2.34M | $1.23M | $20.27M | $3.23M | $3.08M | $2.98M | $2.21M | $3.51M |
| Cost of Revenue | $627K | $1.03M | $1.16M | $2.20M | $532K | $527K | $515K | $557K |
| **Gross Profit** | $1.72M | $194K | $19.11M | $1.03M | $2.55M | $2.45M | $1.70M | $2.95M |
| Research & Development | $3.61M | $3.34M | $3.93M | $14.31M | $3.66M | $3.27M | $3.73M | $4.53M |
| Selling, General & Admin | $4.13M | $4.46M | $5.00M | $7.16M | $6.13M | $7.19M | $7.39M | $6.58M |
| **Operating Income** | -$6.02M | -$7.60M | $10.18M | -$21.24M | -$7.24M | -$8.01M | -$9.42M | -$8.16M |
| **EBITDA** | -$5.55M | -$7.12M | $10.65M | -$20.77M | -$6.76M | -$7.53M | -$8.94M | -$7.68M |
| Interest Expense | $156K | $161K | $699K | $132K | $6.0K | -$15K | -$56K | -$110K |
| Income Before Tax | -$5.83M | -$12.80M | $8.72M | -$23.19M | -$9.65M | -$10.56M | -$10.60M | -$10.23M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$6.31M | -$12.70M | -$7.01M | -$23.20M | -$9.50M | -$10.41M | -$10.46M | -$9.92M |
| Basic EPS | -$9.23 | -$39,983,022.07 | -$34,634,974.53 | -- | -$2,032.95 | -$914,108,658.74 | -$1,488,412,563.67 | -- |
| **Diluted EPS** | -$9.23 | -$39,983,022.07 | -$34,634,974.53 | -- | -$2,032.95 | -$914,108,658.74 | -$1,488,412,563.67 | -- |
| Basic Shares Outstanding | 684.4K | 0 | 0 | -- | 4.7K | 0 | 0 | -- |
| Diluted Shares Outstanding | 684.4K | 0 | 0 | -- | 4.7K | 0 | 0 | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $968K | $8.00M | $6.47M | $5.47M | $17.05M | $8.09M | $3.50M | $2.57M | $521K | $951K |
| **Cash & Short-Term Investments** | $968K | $8.00M | $6.47M | $5.47M | $17.05M | $8.09M | $3.50M | $2.57M | $521K | $951K |
| Accounts Receivable, Net | $1.52M | $1.53M | $1.97M | $1.88M | $1.71M | $2.10M | $1.69M | $996K | $468K | $5.0K |
| Inventory | $8.60M | $10.35M | $9.19M | $7.02M | $4.90M | $2.78M | $2.13M | $3.34M | $2.07M | $413K |
| **Total Current Assets** | $20.34M | $32.20M | $27.96M | $22.32M | $28.43M | $17.79M | $9.52M | $8.15M | $3.80M | $2.56M |
| Property, Plant & Equipment, Net | $463K | $464K | $496K | $557K | $650K | $677K | $710K | $761K | $1.22M | $886K |
| Goodwill | -- | -- | -- | -- | -- | -- | -- | $5.21M | $5.21M | $0 |
| Intangible Assets | $16.02M | $18.48M | $20.12M | $22.44M | $22.65M | $24.34M | $26.02M | $31.71M | $33.40M | -- |
| **Total Non-Current Assets** | $17.98M | $21.23M | $22.80M | $25.13M | $24.83M | $25.05M | $26.89M | $32.89M | $39.83M | $1.01M |
| **Total Assets** | $38.32M | $53.42M | $50.76M | $47.45M | $53.27M | $42.84M | $36.41M | $41.04M | $43.63M | $3.56M |
| Accounts Payable | $8.69M | $5.29M | $4.97M | $5.81M | $4.93M | $4.76M | $5.35M | $5.41M | $7.35M | $517K |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | -- | -- | $1.61M | $1.92M |
| Deferred Revenue (Current) | $170K | $170K | -- | -- | -- | -- | -- | -- | $177K | $224K |
| **Total Current Liabilities** | $40.65M | $19.70M | $13.99M | $30.34M | $15.47M | $13.22M | $15.39M | $26.66M | $15.39M | $4.19M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | -- | -- | $10.98M | $1.82M |
| Deferred Revenue (Non-Current) | $382K | $553K | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $16.36M | $24.74M | $31.88M | $18.47M | $25.94M | $12.42M | $450K | $0 | $10.98M | $1.82M |
| **Total Liabilities** | $57.01M | $44.45M | $45.87M | $48.81M | $41.41M | $25.64M | $15.84M | $26.66M | $26.37M | $6.02M |
| **Total Debt (incl. Leases)** | $1.08M | $985K | $1.23M | $1.21M | $1.16M | -- | $337K | -- | $12.59M | $3.74M |
| Common Stock | -- | -- | -- | -- | -- | -- | -- | -- | -- | $1.4K |
| Retained Earnings | -$399.9M | -$346.5M | -$308.2M | -$266.9M | -$219.5M | -$166.9M | -$133.1M | -$94.55M | -$62.40M | -$40.44M |
| Accumulated Other Comp. Income | -$833K | -$467K | -$652K | -$680K | -- | -- | -- | -- | -- | -- |
| **Total Stockholders' Equity** | -- | -- | -- | -- | -- | $17.20M | $10.67M | $5.38M | $17.26M | -$2.45M |
| Total Equity | -$18.69M | $6.49M | $4.90M | -$1.36M | $11.85M | $17.20M | $10.67M | $5.38M | $17.26M | -$2.45M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $5.53M | $3.79M | $7.28M | $968K | $3.53M | $2.21M | $5.69M | $8.00M |
| **Cash & Short-Term Investments** | $5.53M | $3.79M | $7.28M | $968K | $3.53M | $2.21M | $5.69M | $8.00M |
| Accounts Receivable, Net | $554K | $8.0K | $68K | $1.52M | $1.44M | $1.17M | $1.22M | $1.53M |
| Inventory | $6.75M | $7.32M | $7.82M | $8.60M | $10.63M | $10.72M | $10.55M | $10.35M |
| **Total Current Assets** | $16.39M | $17.53M | $20.21M | $20.34M | $29.40M | $27.90M | $30.44M | $32.20M |
| Property, Plant & Equipment, Net | $412K | $417K | $423K | $463K | $483K | $441K | $452K | $464K |
| Intangible Assets | $14.62M | $15.09M | $15.55M | $16.02M | $17.29M | $17.55M | $18.01M | $18.48M |
| **Total Non-Current Assets** | $16.12M | $16.66M | $17.22M | $17.98M | $20.07M | $20.36M | $21.02M | $21.23M |
| **Total Assets** | $32.51M | $34.19M | $37.43M | $38.32M | $49.47M | $48.27M | $51.46M | $53.42M |
| Accounts Payable | $5.78M | $4.79M | $4.96M | $8.69M | $8.44M | $6.62M | $7.03M | $5.29M |
| Deferred Revenue (Current) | $170K | $170K | $170K | $170K | $170K | $170K | $170K | $170K |
| **Total Current Liabilities** | $12.83M | $25.38M | $40.69M | $40.65M | $36.12M | $29.22M | $28.21M | $19.70M |
| Deferred Revenue (Non-Current) | $255K | $298K | $340K | $382K | $425K | $468K | $510K | $553K |
| **Total Non-Current Liabilities** | $1.06M | $3.89M | $12.50M | $16.36M | $8.99M | $12.17M | $19.94M | $24.74M |
| **Total Liabilities** | $13.89M | $29.27M | $53.19M | $57.01M | $45.11M | $41.39M | $48.15M | $44.45M |
| **Total Debt (incl. Leases)** | $1.02M | $1.09M | $1.16M | $1.08M | $1.14M | $1.22M | $1.27M | $985K |
| Retained Earnings | -$409.5M | -$403.7M | -$391.1M | -$399.9M | -$376.9M | -$367.4M | -$356.9M | -$346.5M |
| Accumulated Other Comp. Income | -$1.17M | -$1.24M | -$1.24M | -$833K | -$839K | -$719K | -$700K | -$467K |
| Total Equity | $18.62M | $4.92M | -$15.75M | -$18.69M | $4.36M | $6.88M | $830K | $6.49M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$54.00M | -$39.25M | -$41.90M | -$48.40M | -$52.60M | -$33.81M | -$38.54M | -$32.15M | -$21.97M | -$14.73M |
| Depreciation & Amortization | $1.91M | $1.90M | $2.01M | $1.98M | $1.72M | $1.73M | $1.74M | $1.32M | $584K | $47K |
| Stock-Based Compensation | $831K | $1.64M | $2.11M | $3.32M | $3.97M | $2.82M | $2.99M | $2.02M | $815K | $718K |
| Change in Receivables | $6.0K | $440K | -$88K | -$170K | $2.82M | -$2.84M | -$696K | -$528K | -$166K | $51K |
| Change in Inventory | -$254K | -$1.16M | -$2.17M | -$2.12M | -$2.12M | -$653K | $1.21M | -$1.27M | $128K | -$183K |
| Change in Payables | $3.35M | $328K | -$855K | $902K | $158K | -$743K | -$63K | -$1.94M | $4.19M | -$28K |
| **Operating Cash Flow** | -$23.69M | -$29.38M | -$33.24M | -$33.10M | -$34.97M | -$15.28M | -$20.46M | -$22.73M | -$9.82M | -$14.41M |
| Capital Expenditure | -- | -$16K | -- | -$77K | -$6.0K | -$7.0K | -- | -$6.5K | -- | -$104K |
| **Free Cash Flow** | -- | -$29.40M | -- | -$33.18M | -$34.98M | -$15.29M | -- | -$22.74M | -- | -$14.52M |
| Acquisitions, Net | -- | -- | -- | -- | -- | -- | -- | -- | -$1.56M | -- |
| **Investing Cash Flow** | -$41K | -$231K | -- | -$1.68M | -$6.0K | -$7.0K | -- | -$6.5K | -$1.56M | $2.38M |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | -- | $5.06M | -- |
| Share Repurchases | -- | -- | -- | -- | -- | -- | -- | -$30 | -- | -- |
| **Financing Cash Flow** | $23.67M | $31.20M | $34.23M | $23.18M | $43.94M | $19.49M | $21.77M | $24.55M | $10.68M | $5.28M |
| **Net Change in Cash** | -$170K | $1.53M | $1.00M | -$11.58M | $8.96M | $4.21M | $1.31M | $1.81M | -$702K | -$6.75M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$5.83M | -$12.80M | $8.72M | -$23.19M | -$9.65M | -$10.56M | -$10.60M | -$10.23M |
| Depreciation & Amortization | $473K | $473K | $473K | $477K | $479K | $478K | $479K | $478K |
| Stock-Based Compensation | $168K | $171K | $155K | $116K | $135K | $279K | $301K | $372K |
| Change in Receivables | -$546K | $60K | $1.45M | -$84K | -$264K | $50K | $304K | -$278K |
| Change in Inventory | $570K | $503K | $780K | $29K | $91K | -$165K | -$209K | -$671K |
| Change in Payables | $975K | -$138K | -$3.75M | $249K | $1.81M | -$438K | $1.72M | $751K |
| **Operating Cash Flow** | -$4.93M | -$5.34M | $8.83M | -$5.49M | -$4.69M | -$6.20M | -$7.31M | -$7.83M |
| **Financing Cash Flow** | $3.85M | $1.86M | -$6.62M | $9.79M | $6.26M | $2.65M | $4.97M | $2.83M |
| **Net Change in Cash** | -$1.06M | -$3.47M | $2.23M | $4.30M | $1.32M | -$3.48M | -$2.31M | -$5.27M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 67.2% | 83.3% | 79.1% | 83.1% | 46.2% | 65.1% | 33.9% | 37.4% | 79.8% | 63.3% |
| **Operating Margin** | -398.8% | -263.8% | -351.3% | -287.8% | -939.1% | -283.9% | -501.3% | -698.0% | -785.3% | -9599.8% |
| **Net Profit Margin** | -465.4% | -329.3% | -423.1% | -396.9% | -1213.3% | -360.2% | -667.3% | -727.9% | -503.7% | -10410.9% |
| Return on Equity (ROE) | -- | -- | -- | -- | -- | -196.5% | -361.1% | -597.2% | -127.3% | -- |
| Return on Assets (ROA) | -139.8% | -72.0% | -81.4% | -100.0% | -98.7% | -78.9% | -105.8% | -78.3% | -50.4% | -413.5% |
| Current Ratio | 0.50x | 1.63x | 2.00x | 0.74x | 1.84x | 1.35x | 0.62x | 0.31x | 0.25x | 0.61x |
| Quick Ratio | 0.29x | 1.11x | 1.34x | 0.50x | 1.52x | 1.14x | 0.48x | 0.18x | 0.11x | 0.51x |
| Debt to Equity | -- | -- | -- | -- | -- | -- | 0.03x | -- | 0.73x | -- |
| **Revenue Growth (YoY)** | -1.5% | +19.8% | -18.4% | +175.8% | -53.8% | +62.5% | +30.8% | +1.3% | +2981.6% | -45.2% |
| Gross Profit Growth (YoY) | -20.5% | +26.0% | -22.3% | +396.4% | -67.2% | +211.6% | +18.7% | -52.6% | +3786.7% | -33.6% |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 81.5% | 82.3% | 85.1% | 67.2% | 81.9% | 81.9% | 82.3% | 83.3% |
| **Operating Margin** | -91.2% | -93.1% | -89.0% | -398.8% | -278.5% | -278.1% | -277.3% | -263.8% |
| **Net Profit Margin** | -181.8% | -188.5% | -169.5% | -465.4% | -341.9% | -344.2% | -343.9% | -329.3% |
| Return on Assets (ROA) | -151.4% | -153.3% | -133.9% | -139.8% | -81.4% | -84.2% | -77.2% | -72.0% |
| Current Ratio | 1.28x | 0.69x | 0.50x | 0.50x | 0.81x | 0.95x | 1.08x | 1.63x |
| Quick Ratio | 0.75x | 0.40x | 0.30x | 0.29x | 0.52x | 0.59x | 0.70x | 1.11x |
| **Revenue Growth (YoY)** | -24.0% | -58.9% | +815.6% | -7.8% | -0.8% | +9.5% | -5.8% | -- |
| Gross Profit Growth (YoY) | -32.7% | -92.1% | +1025.0% | -64.9% | -0.6% | +6.9% | -11.6% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
